dc.creator | Rigalli, Juan Pablo | |
dc.creator | Scholz, Paul Niklas | |
dc.creator | Tocchetti, Guillermo Nicolás | |
dc.creator | Ruiz, Maria Laura | |
dc.creator | Weiss, Johanna | |
dc.date.accessioned | 2018-06-28T17:25:30Z | |
dc.date.available | 2018-06-28T17:25:30Z | |
dc.date.created | 2018-06-28T17:25:30Z | |
dc.date.issued | 2017-11 | |
dc.identifier | Rigalli, Juan Pablo; Scholz, Paul Niklas; Tocchetti, Guillermo Nicolás; Ruiz, Maria Laura; Weiss, Johanna; The phytoestrogens daidzein and equol inhibit the drug transporter BCRP/ABCG2 in breast cancer cells: potential chemosensitizing effect; Dr Dietrich Steinkopff Verlag; European Journal of Nutrition; 11-2017; 1-12 | |
dc.identifier | 1436-6207 | |
dc.identifier | http://hdl.handle.net/11336/50397 | |
dc.identifier | 1436-6215 | |
dc.identifier | CONICET Digital | |
dc.identifier | CONICET | |
dc.description.abstract | PURPOSE: The soy isoflavone genistein has been described to up-regulate breast cancer resistance protein (BCRP) and, thus, enhance chemoresistance in breast cancer cells. The aim of this work was to assess the effect of long- and short-term incubation with daidzein, the second most abundant soy isoflavone and its metabolite equol on the expression and activity of P-glycoprotein, multidrug resistance-associated proteins 1 and 2 (MRP1 and MRP2) and BCRP in breast cancer cells.
METHODS: MCF-7 and MDA-MB-231 cells were treated with phytoestrogen concentrations within the range achieved in individuals with a high isoflavone intake. Transporter expression was evaluated at protein and mRNA level through western blot and qRT-PCR, respectively. Transporter activity was determined using doxorubicin, mitoxantrone and carboxy-dichlorofluorescein as substrates.
RESULTS: Daidzein (5 µM) up-regulated MRP2- and down-regulated MRP1 protein expressions in MCF-7 and MDA-MB-231 cells, respectively. Both effects were ER-dependent, as determined using the antagonist ICI 182,780. The decrease in MRP1 mRNA in MDA-MB-231 cells indicates a transcriptional mechanism. On the contrary, MRP2 induction in MCF-7 cells takes place post-transcriptionally. Whereas changes in the transporter expression had a minor effect on the transporter activity, acute incubation with daidzein, R-equol and S-equol led to a strong inhibition of BCRP activity and an increase in the IC50 of BCRP substrates.
CONCLUSIONS: In contrast to previous reports for genistein, daidzein and equol do not provoke a major up-regulation of the transporter expression but instead an inhibition of BCRP activity and sensitization to BCRP substrates. | |
dc.language | eng | |
dc.publisher | Dr Dietrich Steinkopff Verlag | |
dc.relation | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1007/s00394-017-1578-9 | |
dc.relation | info:eu-repo/semantics/altIdentifier/url/https://link.springer.com/article/10.1007%2Fs00394-017-1578-9 | |
dc.rights | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.subject | Breast Cancer | |
dc.subject | Breast Cancer Resistance Protein | |
dc.subject | Chemotherapy | |
dc.subject | Daidzein | |
dc.subject | Equol | |
dc.subject | Phytoestrogens | |
dc.title | The phytoestrogens daidzein and equol inhibit the drug transporter BCRP/ABCG2 in breast cancer cells: potential chemosensitizing effect | |
dc.type | info:eu-repo/semantics/article | |
dc.type | info:ar-repo/semantics/artículo | |
dc.type | info:eu-repo/semantics/publishedVersion | |